Novo Nordisk A/S (NYSE:NVO)

56.78
Delayed Data
As of Apr 27
 +0.13 / +0.23%
Today’s Change
41.72
Today|||52-Week Range
57.68
+34.17%
Year-to-Date

Today’s Trading

Previous close56.65
Today’s open57.67
Day’s range-- - --
Volume2,310,598
Average volume (3 months)1,665,533
Market cap$113.6B
Dividend yield1.34%
Data as of 04/27/2015

Growth & Valuation

Earnings growth (last year)+6.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+14.80%
Revenue growth (last year)+5.60%
P/E ratio5.6
Price/Sales7.05
Price/Book22.44

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.26+0.56%
BMYBristol-Myers Squibb-0.64-0.97%
ACTActavis-10.22-3.46%
ABBVAbbVie-1.05-1.59%
Data as of 04/27/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.48
Annual revenue (last year)$15.7B
Annual profit (last year)$4.7B
Net profit margin29.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Lars Rebien Sørensen
President &
Chief Operating Officer
Kåre Schultz
Corporate headquarters
Gladsaxe, Capital Region

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers